Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 18;20(3):e0319798.
doi: 10.1371/journal.pone.0319798. eCollection 2025.

Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study

Hannah Benedicta Taylor-Abdulai  1 , Edem Kojo Dzantor  2   3 , Nathan Kumasenu Mensah  4 , Mubarick Nungbaso Asumah  5 , Stephen Ocansey  1 , Samuel Kofi Arhin  1 , Precious Barnes  1 , Victor Obiri Opoku  1 , Zakariah Jirimah Mankir  1 , Sylvester Ackah Famieh  1 , Collins Paa Kwesi Botchey  1
Affiliations

Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study

Hannah Benedicta Taylor-Abdulai et al. PLoS One. .

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) vaccine hesitancy is a complex health challenge characterized by a delay in the acceptance or refusal of the vaccination with context-specific determinants. Our study, therefore, assessed the COVID-19 vaccine acceptance among urban dwellers in the Central Region, of Ghana.

Methods: A cross sectional study was conducted between September and November, 2022 using a multi-stage cluster sampling procedure among 377 participants. A modified World Health Organization pretested paper-based questionnaire was administered to study participants. The data was analyzed using Statistical Package for Social Sciences (SPSS) version 26. Descriptive and inferential statistics were carried out and results were summarized into frequencies, percentages, tables, and charts for clarity. A conventional p-value < 0.05 was considered statistically significant.

Results: The study revealed that COVID-19 vaccine acceptance was 20.0% (76/377) and vaccine hesitancy was 80.0% (301/377). Out of the 377 participants, their socio-demographic characteristics showed that the majority were below 25 years 53.8% (203/377), [vaccine acceptance; 36.84% (28/76) vs vaccine hesitancy; 58.14% (175/301)], and females 50.1% (189/377), [vaccine acceptance; 56.58% (43/76) vs vaccine hesitancy; 48.50% (146/301)]. Common reasons for COVID-19 vaccine hesitancy included mistrust of the source of the vaccine, personal belief and experience, mistrust of the drug development process, mistrust in the health system, and mistrust of the pharmaceutical company. Age above 25 years, female, educational levels, senior high school and above, being employed, and hearing of new vaccine had a significance influence on COVID-19 vaccine acceptance.

Conclusion: COVID-19 vaccine acceptance was low with high vaccine hesitancy among participants. The study's findings highlights the importance of addressing vaccine hesitancy through building trust in the vaccine development processes, including the provision of accurate information about the vaccine safety and efficacy. Resolving concerns related to the source of the vaccine and the overall healthcare system are important to address vaccine hesitancy. Policy makers could adopt tailored interventions targeting specific demographic groups, such as the younger population and females to increase vaccine acceptance. Ghana's public health authorities could adopt the findings to re-strategize its urban COVID-19 vaccine campaigns to address misconceptions and misinformation to increase vaccine acceptance.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. COVID-19 vaccine acceptance among participants.
Fig 2
Fig 2. Knowledge of common vaccines.
Fig 3.
Fig 3.. Source of information on COVID-19 vaccines.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Agyekum MW, Afrifa-Anane GF, Kyei-Arthur F, Addo B. Acceptability of COVID-19 EE in Ghana. Advances in Public Health. 2021;2021:1–8. doi: 10.1155/2021/9998176 - DOI
    1. Mesele M. COVID-19 vaccination acceptance and its associated factors in Sodo Town, Wolaita Zone, Southern Ethiopia: cross-sectional study. Infect Drug Resist. 2021:2361-7. - PMC - PubMed
    1. Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–7. doi: 10.1016/j.vaccine.2020.08.043 - DOI - PMC - PubMed
    1. World Health Organization Coronavirus (COVID-19) Dashboard _ WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. 2023. Available from: https://covid19.who.int/.
    1. Asumah MN, Abubakari A, Fosu B, Dzantor EK, Agyapong PD, Harrison SB, et al.. Determinants of COVID-19 vaccine acceptance and hesitancy among healthcare professionals in the Kintampo North Municipality, Bono East Region, Ghana. Ghana Med J. 2022;56(3):152–9. doi: 10.4314/gmj.v56i3.4 - DOI - PMC - PubMed

MeSH terms

Substances